Literature DB >> 880243

Effect of a nutritional shift on the degradation of abnormal proteins in the mouse liver. Decreased degradation during rapid liver growth.

R Amils, R D Conde, O A Scornik.   

Abstract

1. The intravenous injection of puromycin to mice 0.5 min after administration of radioactive leucine resulted in the release of labelled ribosome-bound nascent protein chains with the next 0.5 min. 2. During the subsequent 13 min, 40% of the liver protein radioactivity disappeared. The rate of this process was already maximal 0.5 min after the injection of puromycin, with no apparent lag. 3. Evidence is presented that this phenomenon represents the selective degradation of puromycinyl-peptides: (a) the magnitude of this fraction corresponded to the calculated proportion of protein radioactivity in nascent chains at the time of the puromycin effect; (b) the size distribution of the proteins disappearing between 2 and 14 min was smaller than that of those retained at 14 min; and (c) when the injection of puromycin was delayed for 5 min, or when the leucine pulse was interrupted by the injection of cycloheximide (rather than puromycin), the fraction disappearing within 14 min was much smaller. 4. The degradation of puromycinyl-peptides was much slower in the rapidly growing livers of animals recovering from a protein depletion than in the protein-depleted controls. It is concluded that the large decrease in the overall rates of total liver protein degradation previously described during liver growth is a general phenomenon, also affecting the rate of scavenging of abnormal proteins.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 880243      PMCID: PMC1164801          DOI: 10.1042/bj1640363

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Concerning a possible mechanism for selective capture of cytoplasmic proteins by lysosomes.

Authors:  R T Dean
Journal:  Biochem Biophys Res Commun       Date:  1975-11-17       Impact factor: 3.575

2.  INHIBITION OF HEMOGLOBIN SYNTHESIS BY PUROMYCIN.

Authors:  A MORRIS; R ARLIGHAUS; S FAVELUKES; R SCHWEET
Journal:  Biochemistry       Date:  1963 Sep-Oct       Impact factor: 3.162

3.  The effect of puromycin on rabbit reticulocyte ribosomes.

Authors:  D W ALLEN; P C ZAMECNIK
Journal:  Biochim Biophys Acta       Date:  1962-06-11

4.  Molecular-size-dependent degradation of liver cytosolic proteins in vitro.

Authors:  M Hayashi; Y Natori
Journal:  J Biochem       Date:  1976-01       Impact factor: 3.387

5.  Mutants of Escherichia coli with a defect in the degradation of nonsense fragments.

Authors:  A I Bukhari; D Zipser
Journal:  Nat New Biol       Date:  1973-06-20

6.  Rapid degradation of puromycyl peptides in hepatoma cells and reticulocytes.

Authors:  A McIlhinney; B L Hogan
Journal:  FEBS Lett       Date:  1974-04-01       Impact factor: 4.124

7.  Selective degradation of abnormal proteins in mammalian tissue culture cells.

Authors:  M R Capecchi; N E Capecchi; S H Hughes; G M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

8.  Effect of ATP on protein degradation in rat liver lysosomes.

Authors:  M Hayashi; Y Hiroi; Y Natori
Journal:  Nat New Biol       Date:  1973-04-11

9.  Chain termination: a test for a possible explanation of thalassemia.

Authors:  C Baglioni; B Colombo; M Jacobs-Lorena
Journal:  Ann N Y Acad Sci       Date:  1969-11-20       Impact factor: 5.691

10.  Role of protein degradation in the growth of livers after a nutritional shift.

Authors:  R D Conde; O A Scornik
Journal:  Biochem J       Date:  1976-08-15       Impact factor: 3.857

View more
  2 in total

1.  Decreased protein and puromycinyl-peptide degradation in livers of senescent mice.

Authors:  L Lavie; A Z Reznick; D Gershon
Journal:  Biochem J       Date:  1982-01-15       Impact factor: 3.857

2.  Synthesis and conservation of ribosomal proteins during compensatory renal hypertrophy.

Authors:  W T Melvin; A Kumar; R A Malt
Journal:  Biochem J       Date:  1980-04-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.